OPUS(R) CEA TEST SYSTEM

FDA Premarket Approval P920021 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval to add the cea test system to the opus plus and opus magnum analyzers. The same test system is used on all three instruments

DeviceOPUS(R) CEA TEST SYSTEM
Generic NameSystem, Test, Carcinoembryonic Antigen
ApplicantBEHRING DIAGNOSTICS, INC.
Date Received1995-07-03
Decision Date1996-02-23
PMAP920021
SupplementS001
Product CodeDHX 
Advisory CommitteeImmunology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address BEHRING DIAGNOSTICS, INC. 151 University Ave. westwood, MA 02090

Supplemental Filings

Supplement NumberDateSupplement Type
P920021Original Filing
S001 1995-07-03 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.